Latest Regulatory Approval News

VHM Limited has obtained conditional financial backing of up to A$379 million from Export Finance Australia and the US Export-Import Bank to advance its Goschen Rare Earths and Mineral Sands Project in Victoria.

Freehill Mining reports strong magnetite concentrate grades at its Yerbas Buenas project, while advancing its aggregates business and exploring copper-gold opportunities in Chile.

PYC Therapeutics has kicked off a global Phase 1b repeat dose study of its investigational drug PYC-001 targeting Autosomal Dominant Optic Atrophy, a rare genetic eye disease with no current treatments. Initial dosing has begun, with key data expected in the second half of 2026.

Resouro Strategic Metals has raised CAD$1 million through the first tranche of a private placement, advancing its Tiros Titanium-Rare Earths Project in Brazil. The company plans to use the funds to progress engineering work ahead of a Preliminary Economic Assessment.

Nexsen Limited has initiated clinical trials for its StrepSure® GBS Rapid Sensor, a next-generation diagnostic device aimed at improving maternal health outcomes. The trial's success could pave the way for regulatory approval and early market penetration by the second half of 2026.

PMET Resources has completed a positive lithium-only feasibility study for its Shaakichiuwaanaan Project in Quebec, confirming technical and economic viability for a large-scale spodumene concentrate operation with a targeted final investment decision in 2027.

iTech Minerals has secured all approvals and commenced earthworks for a focused gold-antimony drilling campaign at its Reynolds Range project in the Northern Territory, targeting high-grade mineralisation across three key prospects.

Blue Star Helium Limited is poised to become a key U.S. helium and natural CO2 producer with first production from its Galactica project scheduled for December 2025. The company’s staged development plan and strategic joint venture position it to address growing domestic helium demand amid global supply constraints.

Yari Minerals has announced a substantial 140% increase in its JORC Inferred Coal Resource at the Rolleston South Project in Queensland, now totaling 190 million tonnes. The company is actively drilling to upgrade resource confidence and confirm coal quality, positioning itself for future development.

Gold Mountain Limited has reported significant extensions to its rare earth mineralisation at the Irajuba Down Under Project in Brazil, confirming high-grade total and magnet rare earth oxides and paving the way for resource drilling.

Prominence Energy has extended its agreement to acquire the Gawler Hydrogen Project, allowing more time to secure final regulatory approvals and advance exploration in South Australia.

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.